Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Multiple-dose oral tranexamic acid in enhanced-recovery primary total knee arthroplasty
ChiCTR-IPR-17012265Phase 4Completed
- Sponsor
- West China Hospital of Sichuan University
- Start
- Aug 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of tranexamic acid in knee osteoarthritis (OA) (4 arms), sponsored by West China Hospital of Sichuan University. Primary endpoint: Total blood loss. Started Aug 2017; status: completed.
02
Drugs
tranexamic acid
03
Conditions
knee osteoarthritis (OA)
Beyond the preview
Go deeper on ChiCTR-IPR-17012265.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-IPR-17012265.